FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Prakash Deedwania

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Prakash C Deedwania
New oral anticoagulants in elderly patients with atrial fibrillation.
Rajeev Gupta; Sunil Gupta; Soneil Guptha; Mallikarjuna V Jali; Tulika G Mahanta; Anuj Maheshwari; Banshi Saboo; Vijay Achari; Arthur J Asirvatham; Anil Bhansali; Prakash C Deedwania; Arvind Gupta; Bal Kishan Gupta; Jitendra Singh; Krishna Kumar Sharma
Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control.
Prakash C Deedwania
Ivabradine in heart failure: hope or hype?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Prakash Deedwania (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Prakash C Deedwania
New oral anticoagulants in elderly patients with atrial fibrillation.
The American journal of medicine 2013;126(4):289-96.
2013: Rajeev Gupta; Sunil Gupta; Soneil Guptha; Mallikarjuna V Jali; Tulika G Mahanta; Anuj Maheshwari; Banshi Saboo; Vijay Achari; Arthur J Asirvatham; Anil Bhansali; Prakash C Deedwania; Arvind Gupta; Bal Kishan Gupta; Jitendra Singh; Krishna Kumar Sharma
Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control.
American journal of hypertension 2013;26(1):83-94.
2012: Prakash C Deedwania
Ivabradine in heart failure: hope or hype?
American journal of cardiovascular drugs : drugs, devices, and other interventions 2012;12(6):357-9.
2012: Rajeev Gupta; Soneil Guptha; V P Gupta; Aachu Agrawal; Kiran Gaur; Prakash C Deedwania
Twenty-year trends in cardiovascular risk factors in India and influence of educational status.
European journal of preventive cardiology 2012;19(6):1258-71.
2012: Prakash C Deedwania
Heart failure: a common and complex clinical syndrome.
The Medical clinics of North America 2012;96(5):xi-xii.
2012: Joel A Lardizabal; Prakash C Deedwania
Atrial fibrillation in heart failure.
The Medical clinics of North America 2012;96(5):987-1000.
2012: Prakash C Deedwania; Enrique Carbajal
Evidence-based therapy for heart failure.
The Medical clinics of North America 2012;96(5):915-31.
2012: Shradha Rathi; Prakash C Deedwania
The epidemiology and pathophysiology of heart failure.
The Medical clinics of North America 2012;96(5):881-90.
2012: Prakash C Deedwania; Brent M Egan; Das Purkayastha; Rita Samuel; Dion H Zappe; James R Sowers
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(7):415-21.
2012: Jennifer E Ho; Allison Kean; Kiran K Khush; David D Waters; Daniel J Wilson; Chuan-Chuan Wun; Andrei Breazna; Prakash C Deedwania; David A Demicco
Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study).
The American journal of cardiology 2012;109(12):1761-6.
2012: Rajeev Gupta; Sunil Gupta; Soneil Guptha; Mallikarjuna V Jali; Tulika G Mahanta; Anuj Maheshwari; Banshi Saboo; Krishnakumar Sharma; Jitendra Singh; Vijay Achari; Arthur J Asirvatham; Anil Bhansali; Prakash C Deedwania; Arvind Gupta; Balkishan Gupta; Rajiv Gupta
Association of educational, occupational and socioeconomic status with cardiovascular risk factors in Asian Indians: a cross-sectional study.
PloS one 2012;7(8):e44098.
2011: Prakash C Deedwania; Enrique V Carbajal
Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
The American journal of medicine 2011;124(8):681-8.
2011: Prakash C Deedwania; Grace W Huang
Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2011;11(4):265-75.
2011: Prakash C Deedwania
Blood pressure control in diabetes mellitus: is lower always better, and how low should it go?
Circulation 2011;123(24):2776-8.
2011: Prakash C Deedwania; Mustafa I Ahmed; Margaret A Feller; Inmaculada B Aban; Thomas E Love; Bertram Pitt; Ali Ahmed
Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure.
European journal of heart failure 2011;13(5):551-9.
2011: Usman Javed; Prakash C Deedwania; Deepak L Bhatt; Christopher P Cannon; David Dai; Adrian F Hernandez; Eric D Peterson; Gregg C Fonarow
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG).
American heart journal 2011;161(2):418-424.e1-3.
2011: Enrique V Carbajal; Prakash C Deedwania
Role of medical versus interventional strategies to prevent coronary events in patients with stable coronary artery disease.
Cardiology clinics 2011;29(1):157-65.
2011: Joel A Lardizabal; Prakash C Deedwania
Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease.
Cardiology clinics 2011;29(1):87-103.
2011: Prakash C Deedwania
Preface cardiovascular disease prevention: the continuum of primary and secondary prevention.
Cardiology clinics 2011;29(1):xi-xiii.
2011: Joel A Lardizabal; Prakash C Deedwania
The anti-ischemic and anti-anginal properties of statins.
Current atherosclerosis reports 2011;13(1):43-50.
2010: Usman Javed; Prakash C Deedwania; Deepak L Bhatt; Christopher P Cannon; David Dai; Adrian F Hernandez; Eric D Peterson; Gregg C Fonarow
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG).
American heart journal 2010;160(6):1130-6, 1136.e1-3.
2010: Joel A Lardizabal; Prakash C Deedwania
The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus.
Current cardiology reports 2010;12(6):464-71.
2010: Prakash C Deedwania
Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus".
Archives of internal medicine 2010;170(17):1575-7.
2010: James R Sowers; Leopoldo Raij; Ishwarlal Jialal; Brent M Egan; Elizabeth Ofili; Rita Samuel; Dion H Zappe; Das Purkayastha; Prakash C Deedwania
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
Journal of hypertension 2010;28(8):1761-9.
2010: Jennifer E Ho; Vera Bittner; David A Demicco; Andrei Breazna; Prakash C Deedwania; David D Waters
Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
The American journal of cardiology 2010;105(7):905-11.
2010: Joel A Lardizabal; Prakash C Deedwania
The current state of beta blockers in hypertension therapy.
Indian heart journal 2010;62(2):111-7.
2010: Prakash C Deedwania; Joel A Lardizabal
Atrial fibrillation in heart failure: a comprehensive review.
The American journal of medicine 2010;123(3):198-204.
2010: John C LaRosa; Prakash C Deedwania; James Shepherd; Nanette K Wenger; Heiner Greten; David A DeMicco; Andrei Breazna
Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial).
The American journal of cardiology 2010;105(3):283-7.
2010: Joel A Lardizabal; Prakash C Deedwania
Benefits of statin therapy and compliance in high risk cardiovascular patients.
Vascular health and risk management 2010;6():843-53.
2009: Usman Javed; Prakash C Deedwania
Beta-adrenergic blockers for chronic heart failure.
Cardiology in review 2009;17(6):287-92.
2009: Krishna K Sharma; Rajeev Gupta; Aachu Agrawal; Sanjeeb Roy; Atul Kasliwal; Ajeet Bana; Ravindra K Tongia; Prakash C Deedwania
Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
Vascular health and risk management 2009;5():1007-14.
2009: Prakash C Deedwania; Enrique V Carbajal
Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state.
Reviews in cardiovascular medicine 2009;10 Suppl 1():S11-20.
2008: Dion H Zappe; James R Sowers; Willa A Hsueh; Steven M Haffner; Prakash C Deedwania; Vivian A Fonseca; Lucy Keeling; Domenic A Sica
Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(12):894-903.
2008: C Venkata S Ram; Prakash C Deedwania
Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
The American journal of cardiology 2008;102(9):1281-3.
2008: Prakash C Deedwania; Usman Javed
Statins in heart failure.
Cardiology clinics 2008;26(4):573-87.
2008: Usman Javed; Prakash C Deedwania
Angiotensin receptor blockers: novel role in high-risk patients.
Cardiology clinics 2008;26(4):507-26.
2008: James Shepherd; John P Kastelein; Vera A Bittner; Rafael Carmena; Prakash C Deedwania; Andrei Breazna; Stephen Dobson; Daniel J Wilson; Andrea L Zuckerman; Nanette K Wenger
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.
Mayo Clinic proceedings. Mayo Clinic 2008;83(8):870-9.
2008: John B Kostis; Andrei Breazna; Prakash C Deedwania; John C LaRosa
The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(5):367-76.
2008: Rajeev Gupta; V P Gupta; Namita Bhagat; Priyanka Rastogi; Mukesh Sarna; H Prakash; Prakash C Deedwania
Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies.
Indian heart journal 2008;60(1):26-33.
2007: Theodore D Fraker; Stephan D Fihn; Raymond J Gibbons; Jonathan Abrams; Kanu Chatterjee; Jennifer Daley; Prakash C Deedwania; John S Douglas; T. Bruce Ferguson; Julius M Gardin; Robert A O'Rourke; Richard C Pasternak; Sankey V Williams; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; Jonathan L Halperin; Sharon Ann Hunt; Harlan Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina.
Journal of the American College of Cardiology 2007;50(23):2264-74.
2007: Prakash C Deedwania; Milan Gupta; Michael Stein; Joseph Ycas; Alex Gold
Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).
The American journal of cardiology 2007;99(11):1538-43.
2007: Kiran K Khush; David D Waters; Vera Bittner; Prakash C Deedwania; John J P Kastelein; Sandra Lewis; Nanette K Wenger
Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study.
Circulation 2007;115(5):576-83.
2007: Prakash C Deedwania; Dean G Smith
Clinical efficacy and cost-effectiveness of rosuvastatin.
Expert review of pharmacoeconomics & outcomes research 2007;7(1):31-9.
2007: Prakash C Deedwania; Enrique V Carbajal; Vishnu R Bobba
Trials and tribulations associated with angina and traditional therapeutic approaches.
Clinical cardiology 2007;30(2 Suppl 1):I16-24.
2006: Prakash C Deedwania; Roland Schmieder
Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2006;7 Suppl 1():S12-8.
2006: Bertram Pitt; Gregg C Fonarow; Mihai Gheorghiade; Prakash C Deedwania; Daniel A Duprez
Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.
The American journal of cardiology 2006;97(10A):26F-33F.
2006: Prakash C Deedwania; Kevin C Maki; Mary R Dicklin; Neil stone; Christie M Ballantyne; Michael H Davidson
Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
Journal of the cardiometabolic syndrome 2006;1(5):295-300.
2005: Jaime Caro; Kristen Migliaccio-Walle; Judith A O'Brien; William Nova; Jennifer Kim; Ole Hauch; Eric Hillson; Hans Wedel; Ake Hjalmarson; Stephen S Gottlieb; Prakash C Deedwania; John Wikstrand
Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
Journal of cardiac failure 2005;11(9):647-56.
2005: Prakash C Deedwania; Vivian A Fonseca
Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.
The American journal of medicine 2005;118(9):939-47.
2005: Michael H Davidson; Kevin C Maki; Thomas A Pearson; Richard C Pasternak; Prakash C Deedwania; James M McKenney; Gregg C Fonarow; David J Maron; Benjamin J Ansell; Luther Clark; Christie M Ballantyne
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
The American journal of cardiology 2005;96(4):556-63.
2005: Kris Vijayaraghavan; Prakash C Deedwania
The renin angiotensin system as a therapeutic target to prevent diabetes and its complications.
Cardiology clinics 2005;23(2):165-83.
2005: Prakash C Deedwania
Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
Cardiology clinics 2005;23(2):139-52.
2005: Prakash C Deedwania; Donald B Hunninghake; Harold E Bays; Peter H Jones; Valerie A Cain; James W Blasetto
Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.
The American journal of cardiology 2005;95(3):360-6.
2005: Prakash C Deedwania; Thomas D Giles; Michael Klibaner; Jalal K Ghali; Johan Herlitz; Per Hildebrandt; John Kjekshus; Jindrich Spinar; Jiri Vitovec; Hilary Stanbrook; John Wikstrand
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
American heart journal 2005;149(1):159-67.
2004: Prakash C Deedwania
Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE).
American heart journal 2004;148(6):1053-9.
2004: Jalal K Ghali; Peter H J M Dunselman; Finn Waagstein; Sidney Goldstein; Stephen S Gottlieb; Prakash C Deedwania; John Wikstrand
Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis.
Journal of cardiac failure 2004;10(6):452-9.
2004: Prakash C Deedwania
Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes.
Cardiology clinics 2004;22(4):505-9, v.
2004: George Mensah; Ali H Mokdad; Earl Ford; K Narayan; Wayne H Giles; Frank Vinicor; Prakash C Deedwania
Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications.
Cardiology clinics 2004;22(4):485-504.
2004: Rajeev Gupta; Prakash C Deedwania; Arvind Gupta; Shweta Rastogi; Raja B Panwar; Kunal Kothari
Prevalence of metabolic syndrome in an Indian urban population.
International journal of cardiology 2004;97(2):257-61.
2004: Prakash C Deedwania; Michael H Davidson; Christie M Ballantyne
Treating dyslipidemia in high-risk patients: case reviews and discussion.
Postgraduate medicine 2004;116(3 Suppl):21-8.
2004: Prakash C Deedwania; Stephen S Gottlieb; Jalal K Ghali; Finn Waagstein; John C M Wikstrand
Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure.
European heart journal 2004;25(15):1300-9.
2004: Prakash C Deedwania; Donald B Hunninghake; Harold Bays
Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome.
The American journal of cardiology 2004;93(11A):18C-26C.
2004: Prakash C Deedwania
Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease?
Circulation 2004;109(1):2-4.
2003: Prakash C Deedwania
Mechanisms of endothelial dysfunction in the metabolic syndrome.
Current diabetes reports 2003;3(4):289-92.
2003: Susan L Ravnan; Prakash C Deedwania
The rational use of diuretics in heart failure.
Current cardiology reports 2003;5(3):237-42.
2003: Prakash C Deedwania
The key to unraveling the mystery of mortality in heart failure: an integrated approach.
Circulation 2003;107(13):1719-21.
2003: Raymond J Gibbons; Jonathan Abrams; Kanu Chatterjee; Jennifer Daley; Prakash C Deedwania; John S Douglas; T. Bruce Ferguson; Stephan D Fihn; Theodore D Fraker; Julius M Gardin; Robert A O'Rourke; Richard C Pasternak; Sankey V Williams; Raymond J Gibbons; Joseph S Alpert; Elliott M Antman; Loren F Hiratzka; Valentin Fuster; David P Faxon; Gabriel Gregoratos; Alice K Jacobs; Sidney C Smith
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).
Circulation 2003;107(1):149-58.
2003: Raymond J Gibbons; Jonathan Abrams; Kanu Chatterjee; Jennifer Daley; Prakash C Deedwania; John S Douglas; T. Bruce Ferguson; Stephan D Fihn; Theodore D Fraker; Julius M Gardin; Robert A O'Rourke; Richard C Pasternak; Sankey V Williams
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina).
Journal of the American College of Cardiology 2003;41(1):159-68.
2003: Prakash C Deedwania
Diabetes and vascular disease: common links in the emerging epidemic of coronary artery disease.
The American journal of cardiology 2003;91(1):68-71.
2002: Prakash C Deedwania
Heart failure in the elderly: is beta-blockade the standard of care?
Postgraduate medicine 2002;112(6 Suppl Heart):21-7.
2002: Mazen Matalka; Marcus C Ravnan; Prakash C Deedwania
Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS).
American heart journal 2002;144(4):674-7.
2002: Helen Q Reynolds; Prakash C Deedwania
Treating hypertension in patients with diabetes.
The Nurse practitioner 2002;27(7):11-21; quiz 21-3.
2002: Jalal K Ghali; Ileana L Piña; Stephen S Gottlieb; Prakash C Deedwania; John C Wikstrand
Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Circulation 2002;105(13):1585-91.
2002: Prakash C Deedwania
The changing face of hypertension: is systolic blood pressure the final answer?
Archives of internal medicine 2002;162(5):506-8.
2002: Susan L Ravnan; Marcus C Ravnan; Prakash C Deedwania
Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure.
Congestive heart failure (Greenwich, Conn.) 2002;8(2):80-5.
2001: YP Sun; Bo-qing Zhu; Amanda E M Browne; S Pulukurthy; Tony M Chou; Krishnankutty Sudhir; Stanton A Glantz; Prakash C Deedwania; Kanu Chatterjee; William W Parmley
Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
Journal of cardiovascular pharmacology and therapeutics 2001;6(2):175-81.
1999: Stuart J Hutchison; Krishnankutty Sudhir; Richard E Sievers; Bo-qing Zhu; YP Sun; Tony M Chou; Kanu Chatterjee; Prakash C Deedwania; john cooke; Stanton A Glantz; William W Parmley
Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke.
Hypertension 1999;34(1):44-50.
1998: Prakash C Deedwania; B N Singh; K Ellenbogen; S Fisher; R Fletcher; S N Singh
Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators.
Circulation 1998;98(23):2574-9.
1998: Stuart J Hutchison; Stanton A Glantz; Bo-qing Zhu; YP Sun; Tony M Chou; Kanu Chatterjee; Prakash C Deedwania; William W Parmley; Krishnankutty Sudhir
In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats.
Journal of the American College of Cardiology 1998;32(5):1463-7.
1998: Prakash C Deedwania
The deadly quartet revisited.
The American journal of medicine 1998;105(1A):1S-3S.
1998: S P Schwarzacher; Stuart J Hutchison; Tony M Chou; YP Sun; Bo-qing Zhu; Kanu Chatterjee; Stanton A Glantz; Prakash C Deedwania; William W Parmley; Krishnankutty Sudhir
Antioxidant diet preserves endothelium-dependent vasodilatation in resistance arteries of hypercholesterolemic rabbits exposed to environmental tobacco smoke.
Journal of cardiovascular pharmacology 1998;31(5):649-53.
1998: YP Sun; Bo-qing Zhu; Richard E Sievers; E P Norkus; William W Parmley; Prakash C Deedwania
Effects of antioxidant vitamins C and E on atherosclerosis in lipid-fed rabbits.
Cardiology 1998;89(3):189-94.
1997: Bo-qing Zhu; YP Sun; Krishnankutty Sudhir; Richard E Sievers; Amanda E M Browne; L Gao; Stuart J Hutchison; Tony M Chou; Prakash C Deedwania; Kanu Chatterjee; Stanton A Glantz; William W Parmley
Effects of second-hand smoke and gender on infarct size of young rats exposed in utero and in the neonatal to adolescent period.
Journal of the American College of Cardiology 1997;30(7):1878-85.
1997: Prakash C Deedwania; E V Carbajal
Role of beta blockade in the treatment of myocardial ischemia.
The American journal of cardiology 1997;80(9B):23J-28J.
1997: Stuart J Hutchison; M S Reitz; Krishnankutty Sudhir; Richard E Sievers; Bo-qing Zhu; YP Sun; Tony M Chou; Prakash C Deedwania; Kanu Chatterjee; Stanton A Glantz; William W Parmley
Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits.
Hypertension 1997;29(5):1186-91.
1997: Stuart J Hutchison; Krishnankutty Sudhir; Tony M Chou; Richard E Sievers; Bo-qing Zhu; YP Sun; Prakash C Deedwania; Stanton A Glantz; William W Parmley; Kanu Chatterjee
Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta.
Journal of the American College of Cardiology 1997;29(4):800-7.
1997: Prakash C Deedwania; Ezra A Amsterdam; R H Vagelos
Evidence-based, cost-effective risk stratification and management after myocardial infarction. California Cardiology Working Group on Post-MI Management.
Archives of internal medicine 1997;157(3):273-80.
1996: Prakash C Deedwania
Hemodynamic changes as triggers of cardiovascular events.
Cardiology clinics 1996;14(2):229-38.
1995: Prakash C Deedwania
Hemodynamic variability and myocardial ischemia.
Cardiology clinics 1995;13(4):491-500.
1995: Prakash C Deedwania
Clinical perspectives on primary and secondary prevention of coronary atherosclerosis.
The Medical clinics of North America 1995;79(5):973-98.
1995: Prakash C Deedwania
Early intervention in patients with heart failure and left ventricular dysfunction.
The Medical clinics of North America 1995;79(5):1191-203.
1995: E V Carbajal; Prakash C Deedwania
Contemporary approaches in medical management of patients with stable coronary artery disease.
The Medical clinics of North America 1995;79(5):1063-84.
1994: Prakash C Deedwania
Comparison of the prognostic values of ischemia during daily life and ischemia induced by treadmill exercise testing.
The American journal of cardiology 1994;73(6):15B-18B.
1994: Prakash C Deedwania
Prevention of heart failure and postinfarction remodeling.
Cardiology clinics 1994;12(1):155-64.
1994: Prakash C Deedwania
Ventricular arrhythmias in heart failure: to treat or not to treat?
Cardiology clinics 1994;12(1):115-32.
1994: Prakash C Deedwania
Prevalence and prognosis of heart failure.
Cardiology clinics 1994;12(1):1-8.
1993: Prakash C Deedwania; E V Carbajal
Secondary prevention after myocardial infarction. Too many choices, which ones work?
Archives of internal medicine 1993;153(3):285-8.
1992: Prakash C Deedwania; E V Carbajal
Role of myocardial oxygen demand in the pathogenesis of silent ischemia during daily life.
The American journal of cardiology 1992;70(16):19F-24F.
1992: Prakash C Deedwania; E V Carbajal
Ambulatory electrocardiography evaluation of asymptomatic, unstable, and stable coronary artery disease patients for myocardial ischemia.
Cardiology clinics 1992;10(3):417-30.
1992: Teresa De Marco; Prakash C Deedwania; Kanu Chatterjee
Systemic and coronary hemodynamic effects of bepridil in patients with depressed left ventricular function.
The American journal of cardiology 1992;69(11):31D-36D.
1991: Prakash C Deedwania; E V Carbajal
Silent myocardial ischemia. A clinical perspective.
Archives of internal medicine 1991;151(12):2373-82.
1991: Prakash C Deedwania; E V Carbajal
Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia.
The American journal of cardiology 1991;68(13):1279-86.
1991: Prakash C Deedwania; E V Carbajal; J R Nelson; H Hait
Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia.
Journal of the American College of Cardiology 1991;17(4):963-9.
1990: Prakash C Deedwania; E V Carbajal
Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectoris.
The American journal of cardiology 1990;66(17):1151-6.
1990: Prakash C Deedwania; E V Carbajal
Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy.
The American journal of cardiology 1990;65(16):1090-6.
1990: Prakash C Deedwania; E V Carbajal
Silent ischemia during daily life is an independent predictor of mortality in stable angina.
Circulation 1990;81(3):748-56.
1990: Prakash C Deedwania
Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexes.
The American journal of cardiology 1990;65(2):43A-50A; discussion 51A-52A.
1989: Prakash C Deedwania; E V Carbajal
Is silent myocardial ischemia clinically important? Does it have prognostic significance?
Postgraduate medicine 1989;86(7):99-105, 108-10.
1986: Prakash C Deedwania; E V Carbajal
Current perspectives in treatment of angina pectoris.
Postgraduate medicine 1986;80(6):189-96, 199-204.